HK1162124A1 - Ansamycin hydroquinone compositions - Google Patents

Ansamycin hydroquinone compositions

Info

Publication number
HK1162124A1
HK1162124A1 HK12102741.4A HK12102741A HK1162124A1 HK 1162124 A1 HK1162124 A1 HK 1162124A1 HK 12102741 A HK12102741 A HK 12102741A HK 1162124 A1 HK1162124 A1 HK 1162124A1
Authority
HK
Hong Kong
Prior art keywords
ansamycin
hydroquinone compositions
compositions
ansamycin hydroquinone
hydroquinone
Prior art date
Application number
HK12102741.4A
Other languages
English (en)
Chinese (zh)
Inventor
James R Porter
Sonali Puri
Original Assignee
Infinity Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infinity Pharmaceuticals Inc filed Critical Infinity Pharmaceuticals Inc
Publication of HK1162124A1 publication Critical patent/HK1162124A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/46—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom rings with more than six members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/06—Oxygen or sulfur directly attached to a cycloaliphatic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
HK12102741.4A 2008-10-15 2012-03-19 Ansamycin hydroquinone compositions HK1162124A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10564808P 2008-10-15 2008-10-15
PCT/US2009/060819 WO2010045442A1 (en) 2008-10-15 2009-10-15 Ansamycin hydroquinone compositions

Publications (1)

Publication Number Publication Date
HK1162124A1 true HK1162124A1 (en) 2012-08-24

Family

ID=42106888

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12102741.4A HK1162124A1 (en) 2008-10-15 2012-03-19 Ansamycin hydroquinone compositions

Country Status (10)

Country Link
US (1) US8778921B2 (xx)
EP (1) EP2348845A4 (xx)
JP (1) JP5583680B2 (xx)
KR (1) KR20110090925A (xx)
CN (1) CN102245021B (xx)
AU (1) AU2009305755B2 (xx)
CA (1) CA2739928A1 (xx)
HK (1) HK1162124A1 (xx)
IL (1) IL212146A (xx)
WO (1) WO2010045442A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1608626A1 (en) 2003-03-28 2005-12-28 Cornell Research Foundation, Inc. Migrastatin analog compositions and uses thereof
WO2010135426A1 (en) * 2009-05-19 2010-11-25 Infinity Pharmaceuticals, Inc. Methods of treating liposarcoma
CN102659522A (zh) * 2012-05-15 2012-09-12 山东大学 一种2,3,5-三甲基氢醌的简易制备方法和防止其在生产或贮存过程中被氧化的方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
DE3234203A1 (de) 1981-09-17 1983-07-07 Takeda Chemical Industries, Ltd., Osaka Macbecin-derivate und deren herstellung
US4792443A (en) * 1985-12-20 1988-12-20 Warner-Lambert Company Skin bleaching preparations
US4762857A (en) 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
ZA878877B (en) 1986-11-29 1988-05-24 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of diseases caused by viruses
WO1993014215A1 (en) 1992-01-06 1993-07-22 Pfizer Inc. Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone
US5387584A (en) 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
CA2166320A1 (en) 1993-06-29 1995-01-12 Randall James Gallaschun Ansamycin derivatives as antioncogene and anticancer agents
US5932566A (en) 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
JP2001516329A (ja) 1995-06-07 2001-09-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ポリヌクレオチド複合体の安定化
MY120063A (en) 1997-12-09 2005-08-30 Lilly Co Eli Stabilized teriparatide solutions
CA2321458A1 (en) 1998-02-18 1999-08-26 Hilmar Meek Warenius Treating cancer
CA2430692C (en) 2001-03-30 2011-05-31 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Geldanamycin derivative and use of same to treat cancer
US6872715B2 (en) 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
AU2002330998A1 (en) 2001-08-06 2003-02-24 Kosan Biosciences, Inc. Benzoquinone ansamycins
EP1435939B1 (en) 2001-09-24 2008-02-27 Conforma Therapeutic Corporation Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
DE60327994D1 (de) 2002-02-08 2009-07-30 Conforma Therapeutics Corp Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften
PT2283856T (pt) 2002-06-21 2017-12-26 Novo Nordisk Healthcare Ag Composições sólidas estabilizadas de polipéptidos do fator viia
JP2006514994A (ja) 2003-03-13 2006-05-18 コンフォーマ・セラピューティクス・コーポレイション 長鎖および中鎖トリグリセリドを有する医薬製剤
ES2409351T3 (es) * 2003-12-23 2013-06-26 Infinity Discovery, Inc. Análogos de ansamicinas que contienen benzoquinona para el tratamiento de cáncer
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
US20070048323A1 (en) 2004-02-20 2007-03-01 Rubin J P Antibody treatment of lipomatous tumors
CN1997632A (zh) 2004-03-26 2007-07-11 范安德尔研究协会 格尔德霉素及其衍生物抑制癌侵入及识别新靶点
EP1863769A4 (en) 2005-03-11 2009-03-18 Univ Colorado HSP90 INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND THEIR APPLICATIONS
JP2007001049A (ja) 2005-06-21 2007-01-11 Sumitomo Heavy Ind Ltd 成型条件設定方法
US20100279994A1 (en) * 2005-06-21 2010-11-04 Inifinity Discovery, Inc. Ansamycin Formulations and Methods of Use Thereof
JP5221131B2 (ja) 2005-06-29 2013-06-26 協和発酵キリン株式会社 ベンゼノイドアンサマイシン誘導体
EP1954265A2 (en) 2005-12-01 2008-08-13 Conforma Therapeutics Corporation Compositions containing ansamycin
KR101315610B1 (ko) * 2006-09-22 2013-10-10 파마시클릭스, 인코포레이티드 브루톤 티로신 키나제 억제제
JP4976830B2 (ja) * 2006-12-01 2012-07-18 東洋ゴム工業株式会社 空気入りタイヤ
PE20081506A1 (es) * 2006-12-12 2008-12-09 Infinity Discovery Inc Formulaciones de ansamicina
MX2009010808A (es) * 2007-04-12 2009-10-29 Infinity Discovery Inc Formulaciones de ansamicina de hidroquinona.

Also Published As

Publication number Publication date
CA2739928A1 (en) 2010-04-22
JP5583680B2 (ja) 2014-09-03
IL212146A (en) 2016-03-31
EP2348845A1 (en) 2011-08-03
JP2012505911A (ja) 2012-03-08
KR20110090925A (ko) 2011-08-10
CN102245021B (zh) 2014-09-17
US8778921B2 (en) 2014-07-15
CN102245021A (zh) 2011-11-16
WO2010045442A1 (en) 2010-04-22
AU2009305755A1 (en) 2010-04-22
IL212146A0 (en) 2011-06-30
AU2009305755B2 (en) 2014-09-18
EP2348845A4 (en) 2013-01-23
US20110263563A1 (en) 2011-10-27

Similar Documents

Publication Publication Date Title
HUE059978T2 (hu) Kompozíciók
GB0810404D0 (en) Compositions
ZA201103926B (en) Stable sulfoximine-insecticide compositions
EP2295613A4 (en) ALLOY ON Mg BASE
HK1159668A1 (en) Multi-cure compositions
GB0812041D0 (en) Compositions
EP2246393A4 (en) CURABLE COMPOSITION
GB0808537D0 (en) Compositions
GB0801119D0 (en) Composition
GB0818804D0 (en) Compositions
PL2303024T3 (pl) Kompozycje biobójcze
EP2248835A4 (en) HARDENING COMPOSITION
EP2327807A4 (en) OXIDDISPERSION REINFORCED ALLOY
GB0801401D0 (en) Composition
EP2357204A4 (en) COMPOSITION
EP2383310A4 (en) HARDENING COMPOSITION
PT2376060E (pt) Composições de nanopartículas
GB0811090D0 (en) Alloys
HK1162124A1 (en) Ansamycin hydroquinone compositions
IL201283A0 (en) Hydroquinone ansamycin formulations
EP2259934A4 (en) NEW MIKTOPOLYMERIC COMPOSITIONS
GB0811534D0 (en) Alloy
GB0804031D0 (en) Composition
ZA201007803B (en) Ferritic alloy compositions
PL2224914T3 (pl) Kompozycje diacereiny

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181015